Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amgen, Apellis, Arch, Arcturus, Argenx, BMS, Corvus, Cytokinetics, Eureka, FSD, Fulcrum, Gilead, Histogen, Inmune Bio, Kodiak, Meiragtx, Northwest, Oculis, Tarsius, Viiv, Zai.